IGC Pharma(IGC) - 2022 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number: 001-32830 INDIA GLOBALIZATION CAPITAL, INC. (Exact name of registrant as specified in its charter) Maryland (I.R.S. Employer Identification No.) (State or other jurisdiction of incorporation or organization) 10224 Falls Road, Potomac, Maryland (Address of principal executive offices) (301) 983-0998 ☑ Quarterly rep ...